FIB-918

N/A

Report date: 2024/03/14 11:21:44

Base Information

Drug NameFIB-918
Drug Alias NameFIB918FIB-918
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionDiscoidin domain receptors modulatorsIntegrin modulators
TargetsDiscoidin domain receptorsIntegrin
Therapy Area/IndicationsNephritis, Hereditary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFibrocor Therapeutics LP
China Registration ClassN/A

Develop Information

Active CompaniesFibrocor Therapeutics LPMcQuade Center for Strategic Research and Development LLC
Inactive CompaniesN/A
Active IndicationsNephritis, Hereditary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A